Finacea - 50419-825-01 - (azelaic acid)

Alphabetical Index


Drug Information of Finacea

Product NDC: 50419-825
Proprietary Name: Finacea
Non Proprietary Name: azelaic acid
Active Ingredient(s): .15    g/g & nbsp;   azelaic acid
Administration Route(s): TOPICAL
Dosage Form(s): GEL
Coding System: National Drug Codes(NDC)

Labeler Information of Finacea

Product NDC: 50419-825
Labeler Name: Bayer HealthCare Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021470
Marketing Category: NDA
Start Marketing Date: 20021224

Package Information of Finacea

Package NDC: 50419-825-01
Package Description: 10 TUBE in 1 CASE (50419-825-01) > 30 g in 1 TUBE

NDC Information of Finacea

NDC Code 50419-825-01
Proprietary Name Finacea
Package Description 10 TUBE in 1 CASE (50419-825-01) > 30 g in 1 TUBE
Product NDC 50419-825
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name azelaic acid
Dosage Form Name GEL
Route Name TOPICAL
Start Marketing Date 20021224
Marketing Category Name NDA
Labeler Name Bayer HealthCare Pharmaceuticals Inc.
Substance Name AZELAIC ACID
Strength Number .15
Strength Unit g/g
Pharmaceutical Classes Decreased Protein Synthesis [PE],Decreased Sebaceous Gland Activity [PE]

Complete Information of Finacea


General Information